Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER

BACKGROUND: A number of single-inhaler triple therapies are being developed for asthma, including the extrafine formulation of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium (G). Given asthma is a heterogenous disease, we investigated whether the clinical response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Virchow, Johann Christian, Canonica, Giorgio Walter, Vele, Andrea, Kots, Maxim, Georges, George, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597025/
https://www.ncbi.nlm.nih.gov/pubmed/33121501
http://dx.doi.org/10.1186/s12931-020-01558-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597025/
https://www.ncbi.nlm.nih.gov/pubmed/33121501
http://dx.doi.org/10.1186/s12931-020-01558-y

Ejemplares similares